Hong Kong to launch new medical products regulator aimed at global innovation
Hong Kong will establish the Hong Kong Centre for Medical Products Regulation by year-end, seeking international credibility and faster access to drugs and devices.
A new authority, the Hong Kong Centre for Medical Products Regulation, is set to be created before the end of the year, with Li Zili appointed as its controller. The centre will add a “primary evaluation” step to the existing framework, aiming to speed up the clinical rollout of pharmaceuticals and devices. Li emphasized the goal of building a scientifically transparent regulator that earns trust beyond Hong Kong’s borders.
He also highlighted plans for an interdisciplinary scientific team focused on clinical review to boost international cooperation. Health Director Ronald Lam expressed confidence in Li’s practical regulatory background and leadership, noting the centre’s potential to act as a bridge between mainland China and the global market while driving medical innovation.
Why it matters
The regulator could speed patient access to new treatments and raise Hong Kong’s standing in global health governance.
In this story
